Roche unit develops new testing kits to detect mutations in omicron variant

0
56

Roche ROG, -0.33% and its newly acquired subsidary TIB Molbiol said Friday that they have developed three new research test kits to differentiate mutations in the omicron variant of coronavirus that causes COVID. The Swiss pharmaceutical announced the new kits are among the first to specify those mutations, and can help manage the pandemic. “Use of these new tests assess the spread of circulating variants and can help monitor the potential impact of therapeutics, vaccines, and public health interventions,” said the company in a statement. Roche said after analyzing publicly available sequences of the omicron variant, it has concluded that all Roche PCR tests correctly identify the new variant.

This article was originally published by Marketwatch.com. Read the original article here.

Previous article: Burger King selling 37-cent Whoppers through Saturday
Next articlePersonal Finance Daily: Will your home insurance cover these winter disasters and the top 3 places to invest in real estate today

LEAVE A REPLY

Please enter your comment!
Please enter your name here